港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

復宏漢霖

83.850

+0.8000.96%

成交量：41.62萬

成交額：3,465.84萬

市值：455.31億

市盈率：48.43

高：84.350

開：82.400

低：81.300

收：83.050

52周最高：92.000

52周最低：32.000

股本：5.43億

香港流通股本：3.46億

量比：0.83

換手率：0.12%

股息：- -

股息率：- -

每股收益(LYR):1.732

淨資產收益率：23.72%

總資產收益率：4.45%

市淨率：10.02

市盈率(LYR):48.43

市銷率: 5.95

資料載入中...

總覽公司新聞資訊公告

復宏漢霖(02696)：中國證監會就本公司H股全流通出具備案通知書

復宏漢霖：「全球化2.0」戰略與中長期創新藍圖丨JPM大會

JPM 2026引爆中國資產搶籌戰，誰是下一匹黑馬？

医药魔方Info

復宏漢霖貝伐珠單抗生物類似藥在美申報上市，衝擊六大實體瘤領域

加速自免炎症佈局，復星醫藥子公司復宏漢霖引進靶向IL-1RAP創新型單抗

复星医药官微

每日沽空追蹤 | 復宏漢霖 01月15日沽空量成交3900股，沽空比例為1.52%

復宏漢霖引進一款長效單抗新藥

丁香园 Insight 数据库

中生製藥12億收購赫吉亞，金域醫學預虧，沃華醫藥淨利預增逾119%，石藥集團1類新藥在美獲批臨床

復宏漢霖貝伐珠單抗注射液漢貝泰®獲FDA受理生物製品許可申請

復宏漢霖(02696)：漢貝泰® (貝伐珠單抗注射液)的生物製品許可申請(BLA) 獲美國食品藥品管理局(FDA)受理

每日沽空追蹤 | 復宏漢霖 01月13日沽空量成交3.15萬股，沽空比例為3.06%

港股異動 | 復宏漢霖(02696)再升逾8% 廣譜抗腫瘤PD-L1 ADC HLX43末線食管鱗癌II期數據首次發布

復宏漢霖盤中異動早盤快速上漲5.03%報67.850港元

ASCO GI 2026 | 復星醫藥子公司復宏漢霖抗PD-1單抗H藥消化道腫瘤領域兩項結/直腸癌研究數據發布

復宏漢霖：PD-L1 ADC再獲臨床突破，末線食管癌療效優異

每日沽空追蹤 | 復宏漢霖 01月08日沽空量成交1.09萬股，沽空比例為1.51%

港股異動 | 復宏漢霖(02696)盤中升逾5% 公司首次公布PD-L1 ADC食管鱗狀細胞癌Ⅱ期臨床數據

26ASCO GI丨復宏漢霖首次公布PD-L1 ADC食管鱗癌Ⅱ期數據

羅氏老藥因「説明滯後」無法報銷，國內類似藥「兩難」

每日沽空追蹤 | 復宏漢霖 01月07日沽空量成交2.03萬股，沽空比例為2.41%

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02696/news?page=8"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02696","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02696\",,,,,undefined,":{"symbol":"02696","market":"HK","secType":"STK","nameCN":"復宏漢霖","latestPrice":83.85,"timestamp":1776398700006,"preClose":83.05,"halted":0,"volume":416200,"delay":0,"changeRate":0.009632751354605625,"floatShares":346074397,"shares":543000000,"eps":1.7316394175395746,"marketStatus":"午間休市","change":0.8,"latestTime":"04-17 12:05:00","open":82.4,"high":84.35,"low":81.3,"amount":34658370,"amplitude":0.036725,"askPrice":83.85,"askSize":2100,"bidPrice":83.8,"bidSize":2200,"shortable":3,"etf":0,"ttmEps":1.7320775987599233,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1776402000000},"marketStatusCode":3,"adr":0,"listingDate":1569340800000,"exchange":"SEHK","adjPreClose":83.05,"openAndCloseTimeList":[[1776389400000,1776398400000],[1776402000000,1776412800000]],"volumeRatio":0.826573,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02696\",,,,,undefined,":{"symbol":"02696","floatShares":346074397,"roa":"4.45%","roe":"23.72%","lyrEps":1.731531,"volumeRatio":0.826573,"shares":543000000,"dividePrice":0,"high":84.35,"amplitude":0.036725,"preClose":83.05,"low":81.3,"week52Low":32,"pbRate":"10.02","psRate":"5.95","week52High":92,"institutionHeld":0,"latestPrice":83.85,"committee":0.023256,"eps":1.7315313141738757,"divideRate":0,"volume":416200,"delay":0,"ttmEps":1.7319694680393003,"open":82.4,"prevYearClose":57.05,"prevWeekClose":83.35,"prevMonthClose":69.75,"prevQuarterClose":69.75,"fiveDayClose":83.35,"twentyDayClose":66.15,"sixtyDayClose":67.4},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02696\",params:#limit:5,,,undefined,":[{"market":"HK","date":"2026-03-20","symbol":"02696","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1773936000000,"reportTimeType":"post","actualEps":null},{"date":"2025-08-25","symbol":"02696","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756085400000,"name":null,"time":"","dateTimestamp":1756051200000,"actualEps":null},{"date":"2025-03-24","symbol":"02696","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742779800000,"name":null,"time":"盤後","dateTimestamp":1742745600000,"actualEps":null},{"market":"HK","date":"2025-02-10","symbol":"02696","reason":null,"defaultRemindTime":1739151000000,"announcedDate":"2024-12-23","type":"delisting","dateTimestamp":1739116800000},{"market":"HK","date":"2024-08-26","symbol":"02696","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1724601600000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02696\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02696\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.2,"buy":0.8,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8,"analysts":5,"updateTime":1761840000000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02696\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02696","date":"2026-04-15","current":47.938079,"percent":0.908869,"low":-39.586964,"twenty":-10.955096,"median":-6.659976,"eighty":36.908727,"high":139.007258,"avg":13.67816,"sd":36.849996,"marketCap":44919849600},"quantilePoints":[{"date":"2021-04-23","current":-19.645162,"twenty":-19.476333,"median":-18.226089,"eighty":-17.316751,"marketCap":23315929193},{"date":"2021-04-30","current":-19.040057,"twenty":-19.648003,"median":-18.297927,"eighty":-17.448129,"marketCap":22690910112},{"date":"2021-05-07","current":-17.965945,"twenty":-19.565472,"median":-18.363013,"eighty":-17.482435,"marketCap":21549570921},{"date":"2021-05-14","current":-18.113671,"twenty":-19.510182,"median":-18.274791,"eighty":-17.482435,"marketCap":21712619377},{"date":"2021-05-21","current":-18.357986,"twenty":-19.487135,"median":-18.274791,"eighty":-17.516465,"marketCap":22011541546},{"date":"2021-05-28","current":-18.986811,"twenty":-19.432718,"median":-18.278327,"eighty":-17.567256,"marketCap":22989832281},{"date":"2021-06-04","current":-18.085054,"twenty":-19.394728,"median":-18.274791,"eighty":-17.569054,"marketCap":21794143605},{"date":"2021-06-11","current":-17.838307,"twenty":-19.380637,"median":-18.278327,"eighty":-17.596682,"marketCap":21495221436},{"date":"2021-06-18","current":-16.028857,"twenty":-19.316527,"median":-18.226089,"eighty":-17.499595,"marketCap":19158193568},{"date":"2021-06-25","current":-17.449469,"twenty":-19.090843,"median":-18.120466,"eighty":-17.407752,"marketCap":20843027612},{"date":"2021-07-02","current":-17.434433,"twenty":-19.054867,"median":-18.089655,"eighty":-17.397323,"marketCap":20788678127},{"date":"2021-07-09","current":-16.265645,"twenty":-19.040057,"median":-18.074879,"eighty":-17.195892,"marketCap":19375591509},{"date":"2021-07-16","current":-15.969405,"twenty":-19.032975,"median":-18.040488,"eighty":-17.122755,"marketCap":19022319855},{"date":"2021-07-23","current":-15.856864,"twenty":-19.023636,"median":-18.026565,"eighty":-17.079749,"marketCap":18886446141},{"date":"2021-07-30","current":-14.666803,"twenty":-18.986811,"median":-17.998882,"eighty":-16.849549,"marketCap":17527709009},{"date":"2021-08-06","current":-14.588335,"twenty":-18.965589,"median":-17.945733,"eighty":-16.750714,"marketCap":17391835296},{"date":"2021-08-13","current":-14.52296,"twenty":-18.953047,"median":-17.911145,"eighty":-16.470265,"marketCap":17337485810},{"date":"2021-08-20","current":-13.520478,"twenty":-18.945494,"median":-17.88088,"eighty":-16.251298,"marketCap":15217855884},{"date":"2021-08-27","current":-12.980395,"twenty":-18.88847,"median":-17.842996,"eighty":-16.122732,"marketCap":14674361031},{"date":"2021-09-03","current":-12.734842,"twenty":-18.882406,"median":-17.809029,"eighty":-15.859736,"marketCap":14402613604},{"date":"2021-09-10","current":-13.373232,"twenty":-18.846812,"median":-17.803134,"eighty":-15.761703,"marketCap":15163506398},{"date":"2021-09-17","current":-12.138916,"twenty":-18.846135,"median":-17.730953,"eighty":-15.089723,"marketCap":13723245038},{"date":"2021-09-24","current":-11.82096,"twenty":-18.810911,"median":-17.571343,"eighty":-14.867281,"marketCap":13369973383},{"date":"2021-09-30","current":-11.757587,"twenty":-18.785539,"median":-17.567074,"eighty":-14.603567,"marketCap":13342798641},{"date":"2021-10-08","current":-10.872073,"twenty":-18.769634,"median":-17.476946,"eighty":-14.333569,"marketCap":12337333163},{"date":"2021-10-15","current":-12.085096,"twenty":-18.725638,"median":-17.441951,"eighty":-13.86094,"marketCap":13723245038},{"date":"2021-10-22","current":-11.832626,"twenty":-18.639753,"median":-17.36388,"eighty":-13.648942,"marketCap":13533021839},{"date":"2021-10-29","current":-12.004873,"twenty":-18.601961,"median":-17.24697,"eighty":-13.384811,"marketCap":13696070295},{"date":"2021-11-05","current":-11.842443,"twenty":-18.587887,"median":-17.177529,"eighty":-13.069878,"marketCap":13533021839},{"date":"2021-11-12","current":-13.238443,"twenty":-18.539285,"median":-17.121354,"eighty":-12.950721,"marketCap":15190681141},{"date":"2021-11-19","current":-13.755236,"twenty":-18.493787,"median":-17.09849,"eighty":-12.989283,"marketCap":15761350737},{"date":"2021-11-26","current":-15.860878,"twenty":-18.471737,"median":-16.981974,"eighty":-13.021471,"marketCap":18179902832},{"date":"2021-12-03","current":-12.565895,"twenty":-18.441097,"median":-16.849549,"eighty":-12.989283,"marketCap":14429788347},{"date":"2021-12-10","current":-13.678439,"twenty":-18.435344,"median":-16.791123,"eighty":-12.950721,"marketCap":15734175994},{"date":"2021-12-17","current":-13.900665,"twenty":-18.427924,"median":-16.72442,"eighty":-12.950721,"marketCap":15978748678},{"date":"2021-12-24","current":-12.068814,"twenty":-18.41961,"median":-16.57278,"eighty":-12.854432,"marketCap":13886293494},{"date":"2021-12-31","current":-10.392945,"twenty":-18.411685,"median":-16.313069,"eighty":-12.599684,"marketCap":11984061508},{"date":"2022-01-07","current":-10.408899,"twenty":-11.114507,"median":-10.603378,"eighty":-10.458171,"marketCap":11956886766},{"date":"2022-01-14","current":-10.645935,"twenty":-11.136014,"median":-10.825867,"eighty":-10.516719,"marketCap":12255808935},{"date":"2022-01-21","current":-11.846284,"twenty":-11.23402,"median":-10.950741,"eighty":-10.575568,"marketCap":13668895552},{"date":"2022-01-28","current":-10.719633,"twenty":-11.23402,"median":-10.92037,"eighty":-10.575568,"marketCap":12337333163},{"date":"2022-02-04","current":-10.961121,"twenty":-11.226983,"median":-10.955931,"eighty":-10.603378,"marketCap":12609080589},{"date":"2022-02-11","current":-11.151206,"twenty":-11.195149,"median":-10.961121,"eighty":-10.645935,"marketCap":12853653273},{"date":"2022-02-18","current":-10.838643,"twenty":-11.151206,"median":-10.933229,"eighty":-10.645935,"marketCap":12554731104},{"date":"2022-02-25","current":-10.531157,"twenty":-11.149804,"median":-10.879658,"eighty":-10.555938,"marketCap":12228634192},{"date":"2022-03-04","current":-10.223007,"twenty":-11.133246,"median":-10.844907,"eighty":-10.526339,"marketCap":11875362538},{"date":"2022-03-11","current":-8.809298,"twenty":-11.096591,"median":-10.772075,"eighty":-10.439214,"marketCap":10217703236},{"date":"2022-03-18","current":-8.973146,"twenty":-11.067899,"median":-10.693082,"eighty":-10.247041,"marketCap":10859027162},{"date":"2022-03-25","current":-9.408384,"twenty":-11.060746,"median":-10.645935,"eighty":-9.613254,"marketCap":11386217170},{"date":"2022-04-01","current":-8.944167,"twenty":-11.060302,"median":-10.579658,"eighty":-9.555081,"marketCap":10837287368},{"date":"2022-04-08","current":-9.101703,"twenty":-11.051173,"median":-10.532504,"eighty":-9.487781,"marketCap":11032945515},{"date":"2022-04-14","current":-8.829357,"twenty":-10.996229,"median":-10.520302,"eighty":-9.272441,"marketCap":10685108809},{"date":"2022-04-22","current":-8.439191,"twenty":-10.958109,"median":-10.475675,"eighty":-9.02764,"marketCap":10022045089},{"date":"2022-04-29","current":-9.033079,"twenty":-10.95245,"median":-10.408899,"eighty":-8.917879,"marketCap":10554670045},{"date":"2022-05-06","current":-7.41082,"twenty":-10.943736,"median":-10.392945,"eighty":-8.839536,"marketCap":8587218677},{"date":"2022-05-13","current":-7.364351,"twenty":-10.915716,"median":-10.223007,"eighty":-8.8007,"marketCap":8380690633},{"date":"2022-05-20","current":-7.968917,"twenty":-10.889999,"median":-9.98237,"eighty":-8.584099,"marketCap":9195932912},{"date":"2022-05-27","current":-7.542162,"twenty":-10.879658,"median":-9.877618,"eighty":-8.1017,"marketCap":8695917648},{"date":"2022-06-02","current":-7.839485,"twenty":-10.877545,"median":-9.647965,"eighty":-8.02985,"marketCap":9087233942},{"date":"2022-06-10","current":-8.770543,"twenty":-10.856339,"median":-9.531356,"eighty":-7.992051,"marketCap":10098134368},{"date":"2022-06-17","current":-8.742365,"twenty":-10.841148,"median":-9.348726,"eighty":-8.004315,"marketCap":10054654780},{"date":"2022-06-24","current":-8.23701,"twenty":-10.797885,"median":-9.166898,"eighty":-8.03147,"marketCap":9511159927},{"date":"2022-06-30","current":-8.326656,"twenty":-10.778323,"median":-9.060482,"eighty":-8.076162,"marketCap":9598119103},{"date":"2022-07-08","current":-8.497078,"twenty":-10.769546,"median":-8.973146,"eighty":-8.128672,"marketCap":9804647148},{"date":"2022-07-15","current":-8.681154,"twenty":-10.738924,"median":-8.890871,"eighty":-8.173221,"marketCap":9924216015},{"date":"2022-07-22","current":-8.295377,"twenty":-10.687772,"median":-8.843947,"eighty":-8.192495,"marketCap":9489420133},{"date":"2022-07-29","current":-7.886667,"twenty":-10.657029,"median":-8.819327,"eighty":-8.057303,"marketCap":9032884456},{"date":"2022-08-05","current":-7.136107,"twenty":-10.647839,"median":-8.783241,"eighty":-7.981108,"marketCap":8152422795},{"date":"2022-08-12","current":-7.088387,"twenty":-10.632543,"median":-8.711759,"eighty":-7.937979,"marketCap":8108943206},{"date":"2022-08-19","current":-8.891947,"twenty":-10.611473,"median":-8.651267,"eighty":-7.857437,"marketCap":8619828368},{"date":"2022-08-26","current":-9.878492,"twenty":-10.574914,"median":-8.756454,"eighty":-7.879762,"marketCap":9500290030},{"date":"2022-09-02","current":-9.641847,"twenty":-10.542686,"median":-8.8007,"eighty":-7.911799,"marketCap":9239412501},{"date":"2022-09-09","current":-8.585571,"twenty":-10.532235,"median":-8.776892,"eighty":-7.937979,"marketCap":8195902383},{"date":"2022-09-16","current":-8.205928,"twenty":-10.52923,"median":-8.711759,"eighty":-7.947262,"marketCap":7761106500},{"date":"2022-09-23","current":-7.850954,"twenty":-10.521509,"median":-8.645731,"eighty":-7.931397,"marketCap":7282831030},{"date":"2022-09-30","current":-6.666434,"twenty":-10.504967,"median":-8.625033,"eighty":-7.852429,"marketCap":6195841324},{"date":"2022-10-07","current":-6.701906,"twenty":-10.484881,"median":-8.591202,"eighty":-7.761108,"marketCap":6228451015},{"date":"2022-10-14","current":-7.35301,"twenty":-10.456108,"median":-8.583249,"eighty":-7.57143,"marketCap":6761075971},{"date":"2022-10-21","current":-7.951253,"twenty":-10.433151,"median":-8.545175,"eighty":-7.57143,"marketCap":7261091236},{"date":"2022-10-28","current":-6.796392,"twenty":-10.406061,"median":-8.508514,"eighty":-7.508003,"marketCap":6195841324},{"date":"2022-11-04","current":-6.754512,"twenty":-10.394357,"median":-8.473127,"eighty":-7.42644,"marketCap":6217581118},{"date":"2022-11-11","current":-6.097932,"twenty":-10.363764,"median":-8.469242,"eighty":-7.395321,"marketCap":5663216368},{"date":"2022-11-18","current":-6.753098,"twenty":-10.242234,"median":-8.45243,"eighty":-7.346759,"marketCap":6250190809},{"date":"2022-11-25","current":-6.736071,"twenty":-10.196623,"median":-8.439191,"eighty":-7.272097,"marketCap":6184971427},{"date":"2022-12-02","current":-7.773909,"twenty":-10.077914,"median":-8.37957,"eighty":-7.241589,"marketCap":7261091236},{"date":"2022-12-09","current":-8.002157,"twenty":-10.008085,"median":-8.295377,"eighty":-7.250791,"marketCap":7543708559},{"date":"2022-12-16","current":-7.535454,"twenty":-9.932205,"median":-8.278653,"eighty":-7.272097,"marketCap":7087172883},{"date":"2022-12-23","current":-7.51,"twenty":-9.898083,"median":-8.243002,"eighty":-7.316458,"marketCap":7065433089},{"date":"2022-12-30","current":-7.305703,"twenty":-9.88339,"median":-8.22445,"eighty":-7.296997,"marketCap":6956734118},{"date":"2023-01-06","current":-7.457393,"twenty":-9.877968,"median":-8.206319,"eighty":-7.311066,"marketCap":7174132059},{"date":"2023-01-13","current":-8.437239,"twenty":-9.858414,"median":-8.206709,"eighty":-7.320093,"marketCap":8271991662},{"date":"2023-01-20","current":-8.286606,"twenty":-9.834445,"median":-8.240006,"eighty":-7.327535,"marketCap":8054593721},{"date":"2023-01-27","current":-8.57561,"twenty":-9.827001,"median":-8.248307,"eighty":-7.330074,"marketCap":8337211045},{"date":"2023-02-03","current":-8.175491,"twenty":-9.75546,"median":-8.23701,"eighty":-7.341519,"marketCap":7989374339},{"date":"2023-02-10","current":-7.777299,"twenty":-9.742113,"median":-8.206319,"eighty":-7.345196,"marketCap":7554578456},{"date":"2023-02-17","current":-8.009725,"twenty":-9.697444,"median":-8.193537,"eighty":-7.35301,"marketCap":7706757015},{"date":"2023-02-24","current":-8.177484,"twenty":-9.647965,"median":-8.202583,"eighty":-7.359122,"marketCap":7771976397},{"date":"2023-03-03","current":-8.136456,"twenty":-9.641847,"median":-8.205928,"eighty":-7.362303,"marketCap":7782846294},{"date":"2023-03-10","current":-7.532958,"twenty":-7.936227,"median":-7.807589,"eighty":-7.663468,"marketCap":7152392265},{"date":"2023-03-17","current":-6.893844,"twenty":-29.280721,"median":-16.418697,"eighty":-8.337386,"marketCap":6608897412},{"date":"2023-03-24","current":-6.658655,"twenty":-29.278482,"median":-16.330752,"eighty":-8.295377,"marketCap":6456718853},{"date":"2023-03-31","current":-6.382321,"twenty":-29.265473,"median":-16.265645,"eighty":-8.279201,"marketCap":6141491838},{"date":"2023-04-06","current":-6.996826,"twenty":-29.261938,"median":-16.251298,"eighty":-8.277923,"marketCap":6728466280},{"date":"2023-04-14","current":-9.166043,"twenty":-29.244948,"median":-16.177122,"eighty":-8.278324,"marketCap":7282831030},{"date":"2023-04-21","current":-10.375279,"twenty":-29.156297,"median":-16.110434,"eighty":-8.280198,"marketCap":8239381971},{"date":"2023-04-28","current":-9.791172,"twenty":-28.966769,"median":-16.017528,"eighty":-8.284669,"marketCap":7717626912},{"date":"2023-05-05","current":-9.403412,"twenty":-28.879119,"median":-15.969405,"eighty":-8.286606,"marketCap":7424139691},{"date":"2023-05-12","current":-9.274529,"twenty":-28.852641,"median":-15.860307,"eighty":-8.292601,"marketCap":7271961133},{"date":"2023-05-19","current":-8.816242,"twenty":-28.781694,"median":-15.853497,"eighty":-8.295377,"marketCap":6815425456},{"date":"2023-05-25","current":-7.906691,"twenty":-28.683645,"median":-15.812226,"eighty":-8.286122,"marketCap":6087142353},{"date":"2023-06-02","current":-7.650251,"twenty":-28.635789,"median":-15.707766,"eighty":-8.27382,"marketCap":5869744412},{"date":"2023-06-09","current":-7.718055,"twenty":-28.62839,"median":-15.523719,"eighty":-8.241804,"marketCap":5913224000},{"date":"2023-06-16","current":-8.211383,"twenty":-28.539889,"median":-15.189066,"eighty":-8.211383,"marketCap":6261060706},{"date":"2023-06-23","current":-7.66872,"twenty":-28.479972,"median":-15.018009,"eighty":-8.206397,"marketCap":5815394927},{"date":"2023-06-30","current":-8.028021,"twenty":-28.434831,"median":-14.894025,"eighty":-8.185553,"marketCap":6032792868},{"date":"2023-07-07","current":-9.203166,"twenty":-28.42021,"median":-14.728988,"eighty":-8.185553,"marketCap":6902384633},{"date":"2023-07-14","current":-9.275907,"twenty":-28.374356,"median":-14.588335,"eighty":-8.192495,"marketCap":7054563191},{"date":"2023-07-21","current":-9.07511,"twenty":-28.325294,"median":-14.52296,"eighty":-8.195817,"marketCap":6869774941},{"date":"2023-07-28","current":-9.214207,"twenty":-28.276566,"median":-14.467488,"eighty":-8.201914,"marketCap":6967604015},{"date":"2023-08-04","current":-8.538775,"twenty":-28.107178,"median":-14.183362,"eighty":-8.20624,"marketCap":6467588750},{"date":"2023-08-11","current":-8.096561,"twenty":-27.877746,"median":-13.991007,"eighty":-8.191975,"marketCap":6098012250},{"date":"2023-08-18","current":-7.762464,"twenty":-27.830986,"median":-13.842305,"eighty":-8.175132,"marketCap":5804525030},{"date":"2023-08-25","current":-26.697795,"twenty":-27.784384,"median":-13.828395,"eighty":-8.158004,"marketCap":5837134721},{"date":"2023-09-01","current":-29.706597,"twenty":-28.107178,"median":-13.888892,"eighty":-8.170209,"marketCap":6521938236},{"date":"2023-09-08","current":-30.060486,"twenty":-28.420665,"median":-14.123754,"eighty":-8.173421,"marketCap":6521938236},{"date":"2023-09-15","current":-29.580626,"twenty":-28.629171,"median":-14.286381,"eighty":-8.175132,"marketCap":6467588750},{"date":"2023-09-22","current":-28.661921,"twenty":-28.647461,"median":-14.50559,"eighty":-8.176288,"marketCap":6239320912},{"date":"2023-09-29","current":-25.921048,"twenty":-28.629171,"median":-14.562003,"eighty":-8.182864,"marketCap":5652346471},{"date":"2023-10-06","current":-24.561986,"twenty":-28.613095,"median":-14.613721,"eighty":-8.191454,"marketCap":5353424302},{"date":"2023-10-13","current":-26.92125,"twenty":-28.546356,"median":-14.838741,"eighty":-8.194677,"marketCap":5858874515},{"date":"2023-10-20","current":-24.986856,"twenty":-28.505231,"median":-14.94306,"eighty":-8.200576,"marketCap":5429513581},{"date":"2023-10-27","current":-30.077169,"twenty":-28.55348,"median":-15.089723,"eighty":-8.205928,"marketCap":6532808133},{"date":"2023-11-03","current":-36.685816,"twenty":-28.661921,"median":-15.342423,"eighty":-8.206709,"marketCap":7989374339},{"date":"2023-11-10","current":-34.996098,"twenty":-28.781694,"median":-15.589929,"eighty":-8.211383,"marketCap":7619797839},{"date":"2023-11-17","current":139.007258,"twenty":-28.852641,"median":-15.556824,"eighty":-8.205928,"marketCap":8271991662},{"date":"2023-11-24","current":134.06759,"twenty":-28.781694,"median":-15.273067,"eighty":-8.177484,"marketCap":8043723824},{"date":"2023-12-01","current":123.410206,"twenty":-28.717643,"median":-15.018009,"eighty":-8.168722,"marketCap":7435009589},{"date":"2023-12-08","current":115.396674,"twenty":-28.676471,"median":-14.894025,"eighty":-8.136456,"marketCap":6924124427},{"date":"2023-12-15","current":112.572734,"twenty":-28.665909,"median":-14.728988,"eighty":-8.09843,"marketCap":6793685662},{"date":"2023-12-22","current":105.438504,"twenty":-28.661921,"median":-14.588335,"eighty":-8.0768,"marketCap":6358889780},{"date":"2023-12-29","current":124.600197,"twenty":-28.660248,"median":-14.542482,"eighty":-8.068487,"marketCap":7554578456},{"date":"2024-01-05","current":123.318541,"twenty":-28.647461,"median":-14.50559,"eighty":-8.040462,"marketCap":7424139691},{"date":"2024-01-12","current":129.388505,"twenty":-28.629171,"median":-14.286381,"eighty":-8.023906,"marketCap":7793716192},{"date":"2024-01-19","current":128.482233,"twenty":-28.598191,"median":-14.123754,"eighty":-8.004007,"marketCap":7728496809},{"date":"2024-01-26","current":127.895751,"twenty":-28.539232,"median":-13.888892,"eighty":-7.991336,"marketCap":7663277427},{"date":"2024-02-02","current":117.16038,"twenty":-28.492602,"median":-13.828395,"eighty":-7.968917,"marketCap":7011083603},{"date":"2024-02-09","current":116.043963,"twenty":-28.441459,"median":-13.741036,"eighty":-7.955731,"marketCap":6978473912},{"date":"2024-02-16","current":117.464597,"twenty":-28.421577,"median":-13.690402,"eighty":-7.951253,"marketCap":7065433089},{"date":"2024-02-23","current":117.542093,"twenty":-28.419298,"median":-13.613328,"eighty":-7.941856,"marketCap":7032823397},{"date":"2024-03-01","current":119.647539,"twenty":-28.344394,"median":-13.512101,"eighty":-7.915092,"marketCap":7163262162},{"date":"2024-03-08","current":126.672019,"twenty":-28.296644,"median":-13.425131,"eighty":-7.869405,"marketCap":7587188147},{"date":"2024-03-15","current":136.411129,"twenty":-28.24645,"median":-13.3476,"eighty":-7.842873,"marketCap":8163292692},{"date":"2024-03-22","current":12.973937,"twenty":-28.044189,"median":-13.218965,"eighty":-7.777299,"marketCap":7695887118},{"date":"2024-03-28","current":12.519209,"twenty":-28.009087,"median":-13.100065,"eighty":-7.772172,"marketCap":7402399897},{"date":"2024-04-05","current":13.37366,"twenty":-27.959496,"median":-13.038286,"eighty":-7.76525,"marketCap":7902415162},{"date":"2024-04-12","current":13.568308,"twenty":-27.877746,"median":-12.982107,"eighty":-7.733431,"marketCap":8021984030},{"date":"2024-04-19","current":13.635105,"twenty":-27.845088,"median":-12.954555,"eighty":-7.711179,"marketCap":8054593721},{"date":"2024-04-26","current":15.199524,"twenty":-27.834055,"median":-12.900046,"eighty":-7.66971,"marketCap":8967665074},{"date":"2024-05-03","current":15.30222,"twenty":-27.818775,"median":-12.756941,"eighty":-7.639641,"marketCap":9022014559},{"date":"2024-05-10","current":15.81776,"twenty":-27.795706,"median":-12.554537,"eighty":-7.60133,"marketCap":9348111471},{"date":"2024-05-17","current":16.559383,"twenty":-27.750416,"median":-12.52579,"eighty":-7.583293,"marketCap":9772037456},{"date":"2024-05-24","current":17.391151,"twenty":-27.748227,"median":-12.491199,"eighty":-7.548422,"marketCap":10239443030},{"date":"2024-05-31","current":17.373469,"twenty":-27.745702,"median":-12.342599,"eighty":-7.532958,"marketCap":10239443030},{"date":"2024-06-07","current":17.395042,"twenty":-27.698671,"median":-12.324879,"eighty":-7.475268,"marketCap":10239443030},{"date":"2024-06-14","current":17.410995,"twenty":-27.635676,"median":-12.220722,"eighty":-7.447557,"marketCap":10239443030},{"date":"2024-06-21","current":17.44752,"twenty":-27.579411,"median":-12.146878,"eighty":-7.429881,"marketCap":10239443030},{"date":"2024-06-28","current":21.169921,"twenty":-27.531991,"median":-12.107468,"eighty":-7.409463,"marketCap":12418857391},{"date":"2024-07-05","current":21.31352,"twenty":-27.509142,"median":-12.073098,"eighty":-7.391342,"marketCap":12500381619},{"date":"2024-07-12","current":20.958398,"twenty":-27.436,"median":-12.028963,"eighty":-7.356677,"marketCap":12310158420},{"date":"2024-07-19","current":20.772946,"twenty":-27.320477,"median":-12.010321,"eighty":-7.327535,"marketCap":12201459449},{"date":"2024-07-26","current":20.696058,"twenty":-27.195166,"median":-11.942483,"eighty":-7.298439,"marketCap":12201459449},{"date":"2024-08-02","current":20.846486,"twenty":-27.093894,"median":-11.893713,"eighty":-7.252794,"marketCap":12282983677},{"date":"2024-08-09","current":20.754283,"twenty":-27.015113,"median":-11.837535,"eighty":-7.211803,"marketCap":12310158420},{"date":"2024-08-16","current":21.066803,"twenty":-26.967771,"median":-11.806904,"eighty":-7.168418,"marketCap":12500381619},{"date":"2024-08-23","current":20.886927,"twenty":-26.955307,"median":-11.609004,"eighty":-7.109109,"marketCap":12446032133},{"date":"2024-08-30","current":16.43423,"twenty":-26.948522,"median":-11.548619,"eighty":-6.995646,"marketCap":12500381619},{"date":"2024-09-06","current":16.533448,"twenty":-26.930541,"median":-11.45821,"eighty":-6.871599,"marketCap":12581905846},{"date":"2024-09-13","current":16.576841,"twenty":-26.803138,"median":-11.259414,"eighty":-6.79064,"marketCap":12581905846},{"date":"2024-09-20","current":16.406845,"twenty":-26.713756,"median":-11.226983,"eighty":-6.778362,"marketCap":12527556361},{"date":"2024-09-27","current":16.0965,"twenty":-26.474991,"median":-11.12377,"eighty":-6.734055,"marketCap":12364507905},{"date":"2024-10-04","current":16.063334,"twenty":-26.12212,"median":-11.064322,"eighty":-6.695364,"marketCap":12282983677},{"date":"2024-10-10","current":16.275333,"twenty":-25.921214,"median":-11.005246,"eighty":-6.664268,"marketCap":12364507905},{"date":"2024-10-18","current":16.144897,"twenty":-25.637712,"median":-10.902857,"eighty":-6.619301,"marketCap":12201459449},{"date":"2024-10-25","current":15.534605,"twenty":-25.112408,"median":-10.861622,"eighty":-6.595078,"marketCap":11739488824},{"date":"2024-11-01","current":15.739753,"twenty":-24.881781,"median":-10.769967,"eighty":-6.445564,"marketCap":11902537280},{"date":"2024-11-08","current":15.16169,"twenty":-24.562552,"median":-10.648314,"eighty":-6.336141,"marketCap":11413391913},{"date":"2024-11-15","current":14.703704,"twenty":-23.751057,"median":-10.532504,"eighty":12.609275,"marketCap":10951421287},{"date":"2024-11-22","current":14.783679,"twenty":-23.53783,"median":-10.449772,"eighty":13.062987,"marketCap":11005770773},{"date":"2024-11-29","current":15.706785,"twenty":-22.999838,"median":-10.31116,"eighty":13.490644,"marketCap":11685139339},{"date":"2024-12-06","current":16.219845,"twenty":-22.435947,"median":-10.035329,"eighty":13.731242,"marketCap":12038410993},{"date":"2024-12-13","current":16.288608,"twenty":-22.216491,"median":-9.890736,"eighty":14.555832,"marketCap":12065585736},{"date":"2024-12-20","current":17.613984,"twenty":-22.004449,"median":-9.806112,"eighty":14.82169,"marketCap":12989526986},{"date":"2024-12-27","current":17.627659,"twenty":-21.549335,"median":-9.748786,"eighty":14.920514,"marketCap":12989526986},{"date":"2025-01-03","current":17.426208,"twenty":-21.059501,"median":-9.644906,"eighty":15.101644,"marketCap":12853653273},{"date":"2025-01-10","current":17.15965,"twenty":-20.607327,"median":-9.566598,"eighty":15.217942,"marketCap":12609080589},{"date":"2025-01-17","current":14.05661,"twenty":-20.35213,"median":-9.486199,"eighty":15.260472,"marketCap":10337272104},{"date":"2025-01-24","current":11.824511,"twenty":-20.071108,"median":-9.37996,"eighty":15.260472,"marketCap":8750267133},{"date":"2025-01-28","current":12.245071,"twenty":-20.059273,"median":-9.37213,"eighty":15.246556,"marketCap":9108973736},{"date":"2025-02-07","current":14.732138,"twenty":-19.881739,"median":-9.29934,"eighty":15.274388,"marketCap":10897071802},{"date":"2025-02-14","current":15.503935,"twenty":-19.716064,"median":-9.259788,"eighty":15.394257,"marketCap":11440566655},{"date":"2025-02-21","current":15.602496,"twenty":-19.58997,"median":-9.203166,"eighty":15.430255,"marketCap":11576440368},{"date":"2025-02-28","current":20.173929,"twenty":-19.487135,"median":-9.138682,"eighty":15.600316,"marketCap":14918933714},{"date":"2025-03-07","current":22.691836,"twenty":-19.370014,"median":-9.081498,"eighty":15.678831,"marketCap":16848340443},{"date":"2025-03-14","current":22.646997,"twenty":-19.065782,"median":-8.992114,"eighty":15.77216,"marketCap":16821165700},{"date":"2025-03-21","current":22.326485,"twenty":-18.982567,"median":-8.937842,"eighty":15.869892,"marketCap":16576593016},{"date":"2025-03-28","current":21.446687,"twenty":-18.934089,"median":-8.881066,"eighty":15.958854,"marketCap":18832096656},{"date":"2025-04-03","current":20.496847,"twenty":-18.839523,"median":-8.833895,"eighty":16.064644,"marketCap":17962504891},{"date":"2025-04-11","current":17.855677,"twenty":-18.683014,"median":-8.776892,"eighty":16.101901,"marketCap":15543952795},{"date":"2025-04-17","current":21.145085,"twenty":-18.601961,"median":-8.681154,"eighty":16.211906,"marketCap":18451650259},{"date":"2025-04-25","current":23.553782,"twenty":-18.443201,"median":-8.6186,"eighty":16.246671,"marketCap":20571280186},{"date":"2025-05-02","current":25.056257,"twenty":-18.421123,"median":-8.595918,"eighty":16.285953,"marketCap":21930017318},{"date":"2025-05-09","current":21.736701,"twenty":-18.357986,"median":-8.578328,"eighty":16.307243,"marketCap":19158193568},{"date":"2025-05-16","current":24.221218,"twenty":-18.226089,"median":-8.538775,"eighty":16.352589,"marketCap":21522396178},{"date":"2025-05-23","current":25.67354,"twenty":-18.094256,"median":-8.474772,"eighty":16.43423,"marketCap":22881133311},{"date":"2025-05-30","current":28.32371,"twenty":-18.042007,"median":-8.459142,"eighty":16.529212,"marketCap":25354034892},{"date":"2025-06-06","current":27.615744,"twenty":-18.001357,"median":-8.448171,"eighty":16.543914,"marketCap":24783365296},{"date":"2025-06-13","current":28.93664,"twenty":-17.933569,"median":-8.429191,"eighty":16.59113,"marketCap":25979053973},{"date":"2025-06-20","current":29.114781,"twenty":-17.88088,"median":-8.326656,"eighty":16.663735,"marketCap":26087752944},{"date":"2025-06-27","current":30.394421,"twenty":-17.812992,"median":-8.289604,"eighty":17.360329,"marketCap":27310616363},{"date":"2025-07-04","current":33.810314,"twenty":-17.801509,"median":-8.277953,"eighty":17.373683,"marketCap":30381362282},{"date":"2025-07-11","current":31.664802,"twenty":-17.567437,"median":-8.248047,"eighty":17.392581,"marketCap":28424780811},{"date":"2025-07-18","current":38.172983,"twenty":-17.446462,"median":-8.211383,"eighty":17.398695,"marketCap":34240175739},{"date":"2025-07-25","current":37.581872,"twenty":-17.327692,"median":-8.192235,"eighty":17.415819,"marketCap":33832554599},{"date":"2025-08-01","current":40.093578,"twenty":-17.167788,"median":-8.170581,"eighty":17.4341,"marketCap":35870660298},{"date":"2025-08-08","current":44.992727,"twenty":-17.097162,"median":-8.121718,"eighty":17.480128,"marketCap":40354492835},{"date":"2025-08-15","current":50.734499,"twenty":-17.058582,"median":-8.093911,"eighty":17.621631,"marketCap":45436169710},{"date":"2025-08-22","current":50.833217,"twenty":-16.859598,"median":-8.068042,"eighty":18.705535,"marketCap":45381820225},{"date":"2025-08-29","current":46.979642,"twenty":-16.745455,"median":-8.037018,"eighty":20.138159,"marketCap":42338249048},{"date":"2025-09-05","current":49.410758,"twenty":-16.617085,"median":-8.00783,"eighty":20.53569,"marketCap":44485053718},{"date":"2025-09-12","current":47.905886,"twenty":-16.339663,"median":-7.991861,"eighty":20.742638,"marketCap":43207840813},{"date":"2025-09-19","current":46.794173,"twenty":-16.219396,"median":-7.96845,"eighty":20.789539,"marketCap":42175200592},{"date":"2025-09-26","current":43.258153,"twenty":-16.026591,"median":-7.951507,"eighty":20.858338,"marketCap":38887056732},{"date":"2025-10-03","current":44.331295,"twenty":-15.928376,"median":-7.944262,"eighty":20.881711,"marketCap":39946871695},{"date":"2025-10-10","current":43.248336,"twenty":-15.847839,"median":-7.921823,"eighty":20.912054,"marketCap":38914231474},{"date":"2025-10-17","current":43.312255,"twenty":-15.64105,"median":-7.867054,"eighty":20.962367,"marketCap":38941406217},{"date":"2025-10-24","current":42.027527,"twenty":-15.101997,"median":-7.840525,"eighty":21.030606,"marketCap":37800067026},{"date":"2025-10-31","current":42.145948,"twenty":-14.892482,"median":-7.774922,"eighty":21.062977,"marketCap":37963115482},{"date":"2025-11-07","current":36.889434,"twenty":-14.583069,"median":-7.760491,"eighty":21.163007,"marketCap":33207535518},{"date":"2025-11-14","current":40.397492,"twenty":-14.413417,"median":-7.721802,"eighty":21.238988,"marketCap":36468504636},{"date":"2025-11-21","current":38.428633,"twenty":-13.89831,"median":-7.676709,"eighty":21.585681,"marketCap":34674971621},{"date":"2025-11-28","current":41.440339,"twenty":-13.752396,"median":-7.636297,"eighty":22.072269,"marketCap":37528319599},{"date":"2025-12-05","current":40.470534,"twenty":-13.594758,"median":-7.584132,"eighty":22.535186,"marketCap":36713077320},{"date":"2025-12-12","current":38.751278,"twenty":-13.420541,"median":-7.553944,"eighty":23.01359,"marketCap":35218466474},{"date":"2025-12-19","current":37.317799,"twenty":-13.214352,"median":-7.521479,"eighty":23.576306,"marketCap":33995603055},{"date":"2025-12-24","current":35.744771,"twenty":-13.045166,"median":-7.478988,"eighty":23.970387,"marketCap":32664040665},{"date":"2026-01-02","current":34.716008,"twenty":-12.978171,"median":-7.44382,"eighty":24.465877,"marketCap":31848798385},{"date":"2026-01-09","current":39.593777,"twenty":-12.756941,"median":-7.425485,"eighty":25.67354,"marketCap":36414155151},{"date":"2026-01-16","current":40.201825,"twenty":-12.522546,"median":-7.394474,"eighty":26.927257,"marketCap":37093523717},{"date":"2026-01-23","current":34.580238,"twenty":-12.338702,"median":-7.35301,"eighty":28.32371,"marketCap":31875973128},{"date":"2026-01-30","current":33.630532,"twenty":-12.190645,"median":-7.317473,"eighty":29.131639,"marketCap":31142255076},{"date":"2026-02-06","current":37.350776,"twenty":-12.085096,"median":-7.259189,"eighty":29.964257,"marketCap":34674971621},{"date":"2026-02-13","current":40.950166,"twenty":-12.010551,"median":-7.227428,"eighty":30.740387,"marketCap":38234862908},{"date":"2026-02-20","current":42.116804,"twenty":-11.968357,"median":-7.203286,"eighty":31.56008,"marketCap":39267503129},{"date":"2026-02-27","current":38.661558,"twenty":-11.843211,"median":-7.124388,"eighty":32.960436,"marketCap":36441329893},{"date":"2026-03-06","current":40.109289,"twenty":-11.640497,"median":-6.995351,"eighty":33.58367,"marketCap":37501144857},{"date":"2026-03-13","current":38.594557,"twenty":-11.538107,"median":-6.848434,"eighty":33.84606,"marketCap":36251106695},{"date":"2026-03-20","current":37.26014,"twenty":-11.230502,"median":-6.780716,"eighty":34.607392,"marketCap":34865194819},{"date":"2026-03-27","current":41.61299,"twenty":-11.118085,"median":-6.740943,"eighty":35.408925,"marketCap":38968580960},{"date":"2026-04-02","current":44.244207,"twenty":-11.062177,"median":-6.706568,"eighty":36.129285,"marketCap":41631705739},{"date":"2026-04-10","current":47.774541,"twenty":-11.013975,"median":-6.665831,"eighty":36.356348,"marketCap":45300295997},{"date":"2026-04-15","current":47.270445,"twenty":-10.955096,"median":-6.659976,"eighty":36.908727,"marketCap":44919849600}],"updateTime":1776381104951},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02696\",pageSize:20,pageCount:8,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2603966339","title":"復宏漢霖(02696)：中國證監會就本公司H股全流通出具備案通知書","url":"https://stock-news.laohu8.com/highlight/detail?id=2603966339","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603966339?lang=zh_tw&edition=fundamental","pubTime":"2026-01-16 16:31","pubTimestamp":1768552319,"startTime":"0","endTime":"0","summary":"智通财经APP讯，复宏汉霖(02696)发布公告，本公司已于近日接获中国证监会出具的《关于上海复宏汉霖生物技术股份有限公司境内未上市股份“全流通”备案通知书》(备案通知书)。根据备案通知书，本公司就本公司若干股东所持合计1.83亿股非上市股实施H股全流通向中国证监会的备案已完成。若本公司自备案通知书出具之日起12个月内未完成本次H股全流通转换及上市，拟继续推进的，应当向中国证监会更新备案材料。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1393818.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02696","HK0000320264.USD","HK0000306701.USD","HK0000306685.HKD","HK0000165453.HKD","BK1161","HK0000320223.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603396923","title":"復宏漢霖：「全球化2.0」戰略與中長期創新藍圖丨JPM大會","url":"https://stock-news.laohu8.com/highlight/detail?id=2603396923","media":"医药观澜","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603396923?lang=zh_tw&edition=fundamental","pubTime":"2026-01-16 15:10","pubTimestamp":1768547413,"startTime":"0","endTime":"0","summary":"在第44届摩根大通医疗健康年会大会上，复宏汉霖执行董事兼首席执行官朱俊博士于当地时间1月15日在大会上发表主题演讲，系统阐述了公司在全球化2.0阶段的战略路径、创新管线布局及未来中长期发展蓝图。截至目前，复宏汉霖已有10款产品在全球多个国家和地区获批上市。复宏汉霖亦围绕其关键创新资产在2026年的关键临床与注册里程碑，在大会上系统披露了多项明确的时间表与推进计划。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116154204a721ede0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116154204a721ede0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000306685.HKD","HK0000320223.HKD","HK0000165453.HKD","HK0000320264.USD","HK0000306701.USD","BK1161","02696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603951099","title":"JPM 2026引爆中國資產搶籌戰，誰是下一匹黑馬？","url":"https://stock-news.laohu8.com/highlight/detail?id=2603951099","media":"医药魔方Info","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603951099?lang=zh_tw&edition=fundamental","pubTime":"2026-01-16 10:20","pubTimestamp":1768530045,"startTime":"0","endTime":"0","summary":"今年的JPM俨然成了一场围绕中国核心资产的抢筹大战。背后的逻辑是，跨国药企在面临新一轮的管线迭代时，引进中国资产已成为最具性价比的选择之一。除了赛神之外，此次JPM中，受关注度最高，被MNC们密集约会可能非绿叶制药莫属。小结从前两年开始启动的BD潮，到如今JPM2026的火热，无不说明中国资产已是填补MNC管线断层的“必选项”。2026年依旧是中国医药工业“价值兑现”的关键之年。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011610344897a20a37&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011610344897a20a37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0051755006.USD","01530","06160","LU0140636845.USD","LU0417516902.SGD","BK1576","LU0181495838.USD","LU1688375341.USD","LU3063872942.SGD","SG9999002463.SGD","02696","LU0359201612.USD","LU0516422366.SGD","02359","LU0516422952.EUR","LU0516423174.USD","BK1521","IE00B0JY6N72.USD","LU1880383366.USD","02186","LU0516422440.USD","LU0856984785.SGD","09887","LU0052750758.USD","SG9999002562.SGD","01801","LU0516423091.SGD","LU0043850808.USD","LU0456846285.SGD","LU0588546209.SGD","LU0979878070.USD","LU0348825331.USD","LU0708995583.HKD","LU1242518857.USD","LU0456827905.SGD","LU0359202008.SGD","LU0819121731.USD","LU1720050803.USD","BK1610","LU1794554557.SGD","LU2039709279.SGD","LU0320764599.SGD","LU1242518931.SGD","LU0307460666.USD","BK1589","LU0823426308.USD","LU0417516738.SGD","LU0039217434.USD","BK1141","LU0327786744.USD","LU0572944931.SGD","LU0823426480.USD","LU0326950275.SGD","LU0348735423.USD","02269"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603995944","title":"復宏漢霖貝伐珠單抗生物類似藥在美申報上市，衝擊六大實體瘤領域","url":"https://stock-news.laohu8.com/highlight/detail?id=2603995944","media":"药事纵横","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603995944?lang=zh_tw&edition=fundamental","pubTime":"2026-01-16 06:02","pubTimestamp":1768514547,"startTime":"0","endTime":"0","summary":"1月13日，复宏汉霖正式对外宣布，其自主开发的贝伐珠单抗生物类似药汉贝泰的生物制品许可申请已获得FDA正式受理。汉贝泰成为复宏汉霖在美国申报上市的第五款产品。此前，公司的曲妥珠单抗、地舒单抗及帕妥珠单抗生物类似药已在美国成功获批。汉贝泰是复宏汉霖以原研贝伐珠单抗为参照，自主开发的生物类似药，该药已于2021年11月在中国获批上市。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116060521a4c90d6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116060521a4c90d6c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000320264.USD","BK1161","HK0000165453.HKD","HK0000306685.HKD","HK0000320223.HKD","HK0000306701.USD","02696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603959423","title":"加速自免炎症佈局，復星醫藥子公司復宏漢霖引進靶向IL-1RAP創新型單抗","url":"https://stock-news.laohu8.com/highlight/detail?id=2603959423","media":"复星医药官微","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603959423?lang=zh_tw&edition=fundamental","pubTime":"2026-01-15 17:38","pubTimestamp":1768469898,"startTime":"0","endTime":"0","summary":"2026年1月14日，在2026年摩根大通医疗健康大会上，复星医药子公司复宏汉霖宣布与专注肿瘤及炎症疾病创新疗法开发的优迈生物科技（连云港）有限公司签署全球独占许可协议。根据协议，复宏汉霖获得一款具有\"同类最优\"潜力的靶向白介素-1受体辅助蛋白的单克隆抗体的全球独占授权。本次引进的抗IL-1RAP单抗由优迈生物依托其高效的专有抗体发现平台研发，是一款具有完全自主知识产权的多通路抑制长效抗体分子。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115180327a4c72a01&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115180327a4c72a01&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000320264.USD","HK0000306701.USD","HK0000320223.HKD","02196","02696","HK0000306685.HKD","BK1515","BK1191","BK1593","HK0000165453.HKD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603936462","title":"每日沽空追蹤 | 復宏漢霖 01月15日沽空量成交3900股，沽空比例為1.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603936462","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603936462?lang=zh_tw&edition=fundamental","pubTime":"2026-01-15 16:30","pubTimestamp":1768465833,"startTime":"0","endTime":"0","summary":"复宏汉霖北京时间01月15日，涨0.3%，卖空量成交3900股，较上一交易日减少82.03%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115164248a71dca66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115164248a71dca66&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000306701.USD","HK0000165453.HKD","HK0000320223.HKD","02696","HK0000320264.USD","BK1161","HK0000306685.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603936455","title":"復宏漢霖引進一款長效單抗新藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2603936455","media":"丁香园 Insight 数据库","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603936455?lang=zh_tw&edition=fundamental","pubTime":"2026-01-15 10:58","pubTimestamp":1768445904,"startTime":"0","endTime":"0","summary":"1 月 14 日，复宏汉霖宣布与优迈生物签署全球独占许可协议。根据协议，复宏汉霖获得一款具有“同类最优”潜力的靶向白介素-1 受体辅助蛋白的单克隆抗体的全球独占授权。截图来源：企业官微复宏汉霖此次引进的抗 IL-1RAP 单抗是由优迈生物依托其高效的专有抗体发现平台研发，是一款具有完全自主知识产权的多通路抑制长效抗体分子。然而，现有疗法多靶向 IL-1 信号通路下游单一细胞因子，存在疗效局限。目前，全球范围内尚无同靶点类药物获批上市。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011512291897a1e3bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011512291897a1e3bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02696","HK0000320264.USD","HK0000306701.USD","HK0000306685.HKD","HK0000165453.HKD","BK1161","HK0000320223.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603367326","title":"中生製藥12億收購赫吉亞，金域醫學預虧，沃華醫藥淨利預增逾119%，石藥集團1類新藥在美獲批臨床","url":"https://stock-news.laohu8.com/highlight/detail?id=2603367326","media":"谈医说药","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603367326?lang=zh_tw&edition=fundamental","pubTime":"2026-01-13 22:32","pubTimestamp":1768314764,"startTime":"0","endTime":"0","summary":"亨迪药业：公司预计2025年归属净利润为3100万元至3900万元，同比下降57.4%至66.14%。本次发行完成后，中国国际医药卫生有限公司将成为公司的控股股东，公司的实际控制人将变更为国药集团，最终控制人为国务院国资委。上药康丽于2024年4月向国家药监局提出注册上市申请，并获受理。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011323060097a1a8e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011323060097a1a8e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1521","HK0000306701.USD","LU0880133367.SGD","LU1008478684.HKD","LU1152091168.USD","LU1226288170.HKD","LU1813983027.USD","HK0000320264.USD","IE00BZ08YS42.EUR","IE00B543WZ88.USD","BK1515","LU1226287792.SGD","HK0000165453.HKD","LU1152091754.HKD","LU0315179316.USD","LU0501845795.SGD","LU1226288253.USD","LU1807302812.USD","HK0000306685.HKD","01477","LU1951186391.HKD","LU1328277881.USD","03759","HK0000320223.HKD","IE00BZ08YT58.USD","LU1226287875.USD","LU0140636845.USD","BK1161","LU0067412154.USD","LU2039709279.SGD","IE00B031HY20.USD","BK1574","LU0326950275.SGD","01093","IE0008369823.USD","LU1993786604.SGD","02696","LU0072913022.USD","LU1226287529.USD","IE0008368742.USD","LU0314109678.HKD","BK1191","SG9999004220.SGD","LU1960683339.HKD","IE00B5MMRT66.SGD","IE00BZ08YR35.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133202853","title":"復宏漢霖貝伐珠單抗注射液漢貝泰®獲FDA受理生物製品許可申請","url":"https://stock-news.laohu8.com/highlight/detail?id=1133202853","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133202853?lang=zh_tw&edition=fundamental","pubTime":"2026-01-13 16:53","pubTimestamp":1768294393,"startTime":"0","endTime":"0","summary":"上海复宏汉霖生物技术股份有限公司宣布，其自主研发的贝伐珠单抗注射液（商品名：汉贝泰®）的生物制品许可申请（BLA）已正式获得美国食品药品监督管理局（FDA）受理。此次受理标志着该产品向进入美国市场迈出关键一步，也彰显了公司创新研发实力与国际注册能力的提升。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","HK0000320223.HKD","HK0000306701.USD","HK0000306685.HKD","HK0000165453.HKD","HK0000320264.USD","02696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603501958","title":"復宏漢霖(02696)：漢貝泰® (貝伐珠單抗注射液)的生物製品許可申請(BLA) 獲美國食品藥品管理局(FDA)受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2603501958","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603501958?lang=zh_tw&edition=fundamental","pubTime":"2026-01-13 16:53","pubTimestamp":1768294388,"startTime":"0","endTime":"0","summary":"智通财经APP讯，复宏汉霖(02696)发布公告，近日，公司自主研发的汉贝泰® (贝伐珠单抗注射液)(“汉贝泰®”)的生物制品许可申请(“BLA”)获美国食品药品管理局(“FDA”)受理，本次申请涉及的适应症包括：(1)转移性结直肠癌; (2)联合卡铂和紫杉醇一线治疗不可切除的局部晚期、复发性或转移性非鳞状非小细胞肺癌;(3)复发性成人胶质母细胞瘤;(4)联合干扰素α治疗转移性肾细胞癌;(5)上皮性卵巢癌、输卵管癌或原发性腹膜癌;及(6)联合紫杉醇和顺铂，或紫杉醇和拓扑替康治疗持续性、复发性或转移性宫颈癌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1392204.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"复宏汉霖(02696)：汉贝泰® (贝伐珠单抗注射液)的生物制品许可申请(BLA) 获美国食品药品管理局(FDA)受理","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HK0000306701.USD","HK0000320223.HKD","HK0000306685.HKD","BK1161","HK0000165453.HKD","HK0000320264.USD","02696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603636735","title":"每日沽空追蹤 | 復宏漢霖 01月13日沽空量成交3.15萬股，沽空比例為3.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603636735","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603636735?lang=zh_tw&edition=fundamental","pubTime":"2026-01-13 16:30","pubTimestamp":1768293032,"startTime":"0","endTime":"0","summary":"复宏汉霖北京时间01月13日，涨6.42%，卖空量成交3.15万股，较上一交易日增加104.55%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113164507a714fe11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113164507a714fe11&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000165453.HKD","HK0000306685.HKD","HK0000320223.HKD","HK0000320264.USD","HK0000306701.USD","02696","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603539575","title":"港股異動 | 復宏漢霖(02696)再升逾8% 廣譜抗腫瘤PD-L1 ADC HLX43末線食管鱗癌II期數據首次發布","url":"https://stock-news.laohu8.com/highlight/detail?id=2603539575","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603539575?lang=zh_tw&edition=fundamental","pubTime":"2026-01-13 10:12","pubTimestamp":1768270333,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，复宏汉霖再涨超8%，截至发稿，涨8.05%，报69.8港元，成交额1864.08万港元。消息面上，1月9日，复宏汉霖在2026年美国临床肿瘤学会胃肠道肿瘤研讨会上，首度公布了其PD-L1 ADC HLX43治疗复发/转移性食管鳞癌的II期概念验证数据，本次发布的数据初步验证了HLX43在经治的晚期ESCC患者中的治疗潜力，展现出令人鼓舞的疗效及良好的安全性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1392033.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HK0000320223.HKD","LU1169590202.USD","BK1161","BK4023","HK0000306685.HKD","HK0000320264.USD","PD","BK4080","ADC","02696","LU1169589451.USD","BK4231","HK0000306701.USD","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603636788","title":"復宏漢霖盤中異動 早盤快速上漲5.03%報67.850港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603636788","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603636788?lang=zh_tw&edition=fundamental","pubTime":"2026-01-13 09:44","pubTimestamp":1768268665,"startTime":"0","endTime":"0","summary":"2026年01月13日早盘09时44分，复宏汉霖股票出现异动，股价快速拉升5.03%。截至发稿，该股报67.850港元/股，成交量7.54万股，换手率0.05%，振幅6.42%。资金方面，该股资金流入414.538万港元，流出85.6295万港元。复宏汉霖股票所在的生物技术行业中，整体涨幅为1.08%。复宏汉霖公司简介：上海复宏汉霖生物技术股份有限公司是一家主要从事单克隆抗体产品的研发、生产及销售业务的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011309442697a1861a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011309442697a1861a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000320223.HKD","02696","BK1161","HK0000306701.USD","HK0000320264.USD","HK0000306685.HKD","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603544636","title":"ASCO GI 2026 | 復星醫藥子公司復宏漢霖抗PD-1單抗H藥消化道腫瘤領域兩項結/直腸癌研究數據發布","url":"https://stock-news.laohu8.com/highlight/detail?id=2603544636","media":"复星医药","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603544636?lang=zh_tw&edition=fundamental","pubTime":"2026-01-12 17:40","pubTimestamp":1768210811,"startTime":"0","endTime":"0","summary":"在本次大会上，复星医药子公司复宏汉霖创新型抗PD-1单抗H药 汉斯状在MSS/pMMR局部晚期结/直肠癌领域的两项新辅助研究结果以壁报形式正式发布，进一步彰显了H药在消化道肿瘤领域的治疗潜力。在本次ASCO GI大会上，H药公布了两项针对局晚期结/直肠癌的新辅助治疗IIT研究积极结果。2例因不良事件停用。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112210619953c66c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112210619953c66c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000306701.USD","BK1593","BK1191","HK0000320223.HKD","HK0000306685.HKD","02196","BK1161","HK0000165453.HKD","BK1515","HK0000320264.USD","02696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602539621","title":"復宏漢霖：PD-L1 ADC再獲臨床突破，末線食管癌療效優異","url":"https://stock-news.laohu8.com/highlight/detail?id=2602539621","media":"医药笔记","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602539621?lang=zh_tw&edition=fundamental","pubTime":"2026-01-10 09:12","pubTimestamp":1768007535,"startTime":"0","endTime":"0","summary":"复宏汉霖PD-L1 ADC新药HLX43治疗复发或转移性食管鳞癌的二期临床数据首度在此次会议上披露。2例PD-L1联合阳性分数＜1的患者ORR为50.0%，DCR为100%。此次HLX43对于化疗及PD-1后线的三线及以上治疗中仍然获得60%左右的ORR，突破性疗效引人瞩目。除了TMALIN技术之外，HLX43选择了免疫检验点PD-L1作为ADC靶点，在单款产品实现IO+ADC的双重作用机制。总结HLX43为全球第2款PD-L1 ADC，进行了充分的差异化设计，成为其临床突破的坚实基础。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260110102211a709690d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260110102211a709690d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000306685.HKD","HK0000165453.HKD","HK0000320264.USD","BK1161","HK0000320223.HKD","02696","HK0000306701.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602739341","title":"每日沽空追蹤 | 復宏漢霖 01月08日沽空量成交1.09萬股，沽空比例為1.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602739341","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602739341?lang=zh_tw&edition=fundamental","pubTime":"2026-01-08 16:30","pubTimestamp":1767861034,"startTime":"0","endTime":"0","summary":"复宏汉霖北京时间01月08日，涨3.6%，卖空量成交1.09万股，较上一交易日减少70.78%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108164905a7023ec0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108164905a7023ec0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","HK0000320223.HKD","HK0000306701.USD","HK0000306685.HKD","HK0000165453.HKD","HK0000320264.USD","02696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601562331","title":"港股異動 | 復宏漢霖(02696)盤中升逾5% 公司首次公布PD-L1 ADC食管鱗狀細胞癌Ⅱ期臨床數據","url":"https://stock-news.laohu8.com/highlight/detail?id=2601562331","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601562331?lang=zh_tw&edition=fundamental","pubTime":"2026-01-08 11:18","pubTimestamp":1767842338,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，复宏汉霖盘中涨超5%，截至发稿，涨4.39%，报66.65港元，成交额2390.53万港元。其中，复宏汉霖首次公布其PD-L1 ADC药物HLX43治疗复发/转移性食管鳞状细胞癌中的临床数据。HLX43是靶向PD-L1的新型ADC药物，兼具免疫检查点抑制与细胞毒性双重作用，其I期临床已证实对免疫治疗无效患者具有前景疗效和良好耐受性。本项Ⅱ期研究旨在评估HLX43用于经治复发 / 转移性食管鳞状细胞癌患者的疗效与安全性。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1390237.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4231","HK0000165453.HKD","ADC","LU1169589451.USD","LU1169590202.USD","PD","BK4080","02696","BK1161","BK4023"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601333305","title":"26ASCO GI丨復宏漢霖首次公布PD-L1 ADC食管鱗癌Ⅱ期數據","url":"https://stock-news.laohu8.com/highlight/detail?id=2601333305","media":"药研网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601333305?lang=zh_tw&edition=fundamental","pubTime":"2026-01-08 08:00","pubTimestamp":1767830431,"startTime":"0","endTime":"0","summary":"2026年ASCO GI会议即将在召开，官方公布了本次胃肠道肿瘤研讨会摘要内容。其中，复宏汉霖首次公布其PD-L1 ADC药物HLX43治疗复发/转移性食管鳞状细胞癌中的临床数据。HLX43 是靶向 PD-L1 的新型 ADC 药物，兼具免疫检查点抑制与细胞毒性双重作用，其 I 期临床已证实对免疫治疗无效患者具有前景疗效和良好耐受性。本项 Ⅱ 期研究旨在评估 HLX43 用于经治复发 / 转移性食管鳞状细胞癌患者的疗效与安全性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108082422a4a988c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108082422a4a988c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000165453.HKD","BK1161","02696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601876791","title":"羅氏老藥因「説明滯後」無法報銷，國內類似藥「兩難」","url":"https://stock-news.laohu8.com/highlight/detail?id=2601876791","media":"财中社","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601876791?lang=zh_tw&edition=fundamental","pubTime":"2026-01-07 17:37","pubTimestamp":1767778620,"startTime":"0","endTime":"0","summary":"在浙江等部分省份，这种说明书上的“不同步”直接导致了联用方案中的老药美罗华无法报销。国内生物类似药“两难”《财中社》注意到，罗氏的“主动出击”虽然在合规上打通了堵点，却在客观上给国内利妥昔单抗的生物类似药厂家带来显著压力。此外，诸如来那度胺等被广泛用于多种联合疗法中的“搭伙”老药，其说明书的陈旧已成为整个创新药行业共同面临的“集体困境”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107173839a6fe259d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107173839a6fe259d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","LU2097828805.USD","LU2097828474.EUR","06160","BK1589","LU0455707207.USD","BK1574","06978","LU2097828714.EUR","LU2328871848.SGD","BK1161","LU1969619763.USD","LU0502904849.HKD","02696","LU2097828631.EUR","HK0000165453.HKD","01276","LU2097828557.USD","01801","LU2488822045.USD","LU2242644610.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601876772","title":"每日沽空追蹤 | 復宏漢霖 01月07日沽空量成交2.03萬股，沽空比例為2.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601876772","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601876772?lang=zh_tw&edition=fundamental","pubTime":"2026-01-07 16:30","pubTimestamp":1767774633,"startTime":"0","endTime":"0","summary":"复宏汉霖北京时间01月07日，涨2%，卖空量成交2.03万股，较上一交易日减少36.76%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107163511a4a6e777&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107163511a4a6e777&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02696","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":8,"totalSize":200,"code":"91000000","status":"200"}]}}